Eli Lilly and Co. received approval from the FDA for Zepbound (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their sleep disorder. It should be used with a reduced-calorie diet and increased physical activity. OSA is a sleep-related breathing disorder characterized by complete or partial collapses of the upper air...